As an endocytic receptor expressed on antigen-presenting cells, MGL may potentially participate in an anti-tumor defense via antigen uptake and presentation, T cell activation, and the initiation of a specific immune response [69]. This evidence concerns the gene CLEC10A and neoplasm.